Moderna

From booster shots to FDA approval and emergency use authorization to efficacy against the delta variant and more, how do the COVID vaccines compare to each other and which is best for you?

Pfizer said Monday early trial results indicate its COVID-19 vaccine is safe and effective for children ages 5 to 11

A panel of outside experts who advise the Food and Drug Administration voted not to endorse COVID-19 booster shots of the Pfizer vaccine.

With clinical trials underway to determine the safety of both the Pfizer and Moderna COVID vaccines for children under the age of 12, doctors say that data could be released next month that could pave the way for emergency use authorizations for the treatments later this year.

COVID-19 booster shots may be coming for at least some Americans but there’s still important science to be worked out about who really needs them and when. Here’s what we know about the biology behind booster decisions

U.S. health officials say that the Moderna booster shot will need more time to be reviewed which will likely delay President Biden’s plan to offer COVID-19 booster shots to all Americans in mid-September.

With many now able to choose which COVID vaccine they receive, questions surrounding which offers better protection against the now-surging delta variant have spiked.

Researchers in Belgium directly compared the Pfizer and Moderna COVID-19 vaccines by testing the antibodies of 2,500 health care workers after two doses of both vaccines.

Japan is suspending use of about 1.63 million doses of Moderna vaccine after contamination was found in some unused vials

From booster shots to FDA approval to efficacy against the delta variant and more, how do the COVID vaccines compare to each other and which is best for you?

The U.S. gave full approval to Pfizer’s COVID-19 vaccine Monday, potentially boosting public confidence in the shots and instantly opening the way for more universities, companies and local governments to make vaccinations mandatory. NBC 5’s Chris Hush reports.

U.S. health officials are expected to announce that they recommend booster shots of the COVID-19 vaccine eight months after receiving the second dose, according to sources.

U.S. experts are expected to recommend COVID-19 vaccine boosters for all Americans, regardless of age, eight months after they received their second dose of the shot.

A preliminary survey out of Israel suggests that a coronavirus booster shot may cause similar side effects to the second dose.

Vaccine maker Moderna believes people who received two doses of its COVID-19 vaccine will need a third dose before winter as a booster shot. The company said Thursday it is also working on a single shot that would provide an annual booster for COVID-19, as well as flu and the respiratory condition RSV. “We believe that increased force of infection…

Amid reports of some Johnson & Johnson vaccine recipients developing a rare and potentially dangerous neurological reaction, what can you expect if you’re planning to get the one-shot vaccine or already have?

Amid reports of some Johnson & Johnson vaccine recipients developing a rare and potentially dangerous neurological reaction, what can you expect if you’re planning to get the one-shot vaccine or already have?

The CDC confirmed Monday that about 100 cases of Guillain-Barré syndrome, a rare neurological disorder, were found in people who had received the Johnson & Johnson vaccine.

With concerns surrounding the delta coronavirus variant rising globally, how effective are the current vaccines in the U.S. at protecting against the new version of the virus?